Search

Your search keyword '"V Saudek"' showing total 101 results

Search Constraints

Start Over You searched for: Author "V Saudek" Remove constraint Author: "V Saudek"
101 results on '"V Saudek"'

Search Results

51. Human frame shift mutations affecting the carboxyl terminus of perilipin increase lipolysis by failing to sequester the adipose triglyceride lipase (ATGL) coactivator AB-hydrolase-containing 5 (ABHD5).

52. SMED-TLX-1 (NR2E1) is critical for tissue and body plan maintenance in Schmidtea mediterranea in fasting/feeding cycles.

53. Endoplasmic reticulum stress-induced transcription factor, CHOP, is crucial for dendritic cell IL-23 expression.

54. Lichen sclerosus et atrophicus-like skin lesions in a patient carrying a novel hydroxymethylbilane synthase mutation.

55. Prevalence of loss-of-function FTO mutations in lean and obese individuals.

56. Partial lipodystrophy and insulin resistant diabetes in a patient with a homozygous nonsense mutation in CIDEC.

57. Loss-of-function mutation in the dioxygenase-encoding FTO gene causes severe growth retardation and multiple malformations.

58. Acute intermittent porphyria--impact of mutations found in the hydroxymethylbilane synthase gene on biochemical and enzymatic protein properties.

59. Correlation between biochemical findings, structural and enzymatic abnormalities in mutated HMBS identified in six Israeli families with acute intermittent porphyria.

60. The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase.

61. A new mutation within the porphobilinogen deaminase gene leading to a truncated protein as a cause of acute intermittent porphyria in an extended Indian family.

62. BIR-1, a Caenorhabditis elegans homologue of Survivin, regulates transcription and development.

63. Sequence identification and characterization of human carnosinase and a closely related non-specific dipeptidase.

64. Deletion of V335 from the L2 domain of the insulin receptor results in a conformationally abnormal receptor that is unable to bind insulin and causes Donohue's syndrome in a human subject.

65. Structure activity relationship by NMR and by computer: a comparative study.

66. SKIP is an indispensable factor for Caenorhabditis elegans development.

67. The direct determination of protein structure by NMR without assignment.

68. Solution structure of a neurotrophic ligand bound to FKBP12 and its effects on protein dynamics.

69. Mapping the active site of factor Xa by selective inhibitors: an NMR and MD study.

70. 7Li nuclear-magnetic-resonance study of lithium binding to myo-inositolmonophosphatase.

71. Echistatin: the refined structure of a disintegrin in solution by 1H NMR and restrained molecular dynamics.

72. Stimulation of cGMP-dependent protein kinase I alpha by a peptide from its own sequence. An investigation by enzymology, circular dichroism and 1H NMR of the activity and structure of cGMP-dependent protein kinase I alpha-(546-576)-peptide amide.

73. An echistatin C-terminal peptide activates GPIIbIIIa binding to fibrinogen, fibronectin, vitronectin and collagen type I and type IV.

74. Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions.

75. Structure of neuropeptide Y dimer in solution.

76. Three-dimensional structure of acylphosphatase. Refinement and structure analysis.

77. The secondary structure of echistatin from 1H-NMR, circular-dichroism and Raman spectroscopy.

78. 1H NMR and circular dichroism studies of the N-terminal domain of cyclic GMP dependent protein kinase: a leucine/isoleucine zipper.

79. Three-dimensional structure of echistatin, the smallest active RGD protein.

80. The solution structure of a leucine-zipper motif peptide.

81. Solution conformation of endothelin-1 by 1H NMR, CD, and molecular modeling.

82. Solution structure of the basic region from the transcriptional activator GCN4.

83. Solution structure of salmon calcitonin.

84. Solution conformation of endothelin-3 by (1)H NMR and distance geometry calculations.

85. Topological mirror images in protein structure computation: an underestimated problem.

86. Solution structure of the DNA-binding domain of the yeast transcriptional activator protein GCN4.

87. Sequence-specific 1H NMR assignment and secondary structure of neuropeptide Y in aqueous solution.

88. Mobility of secondary structure units of horse-muscle acylphosphatase. Relation to antigenicity.

89. A high-molecular mass derivative of trypsin-kallikrein inhibitor for potential medical use. II. Study of inhibitory activity.

92. Enzyme immobilization techniques on poly(glycidyl methacrylate-co-ethylene dimethacrylate) carrier with penicillin amidase as model.

93. The reaction of Pt-antitumor drugs with selected nucleophiles. II. Preparation and characterization of coordination compounds of Pt(II) and L-histidine.

94. Identification and description of beta-structure in horse muscle acylphosphatase by nuclear magnetic resonance spectroscopy.

95. The reaction of Pt-antitumor drugs with selected nucleophiles. I. The reaction of cis-[Pt(NH3)2Cl2] with glycine.

96. Chromotest estimation of SOS functions as a screening method for antitumor platinum complexes.

97. The sequence-specific assignment of the 1H-NMR spectrum of an enzyme, horse-muscle acylphosphatase.

98. Identification and description of alpha-helical regions in horse muscle acylphosphatase by 1H nuclear magnetic resonance spectroscopy.

99. Secondary structure of acylphosphatase from rabbit skeletal muscle. A nuclear magnetic resonance study.

100. 1H-NMR study of endothelin, sequence-specific assignment of the spectrum and a solution structure.

Catalog

Books, media, physical & digital resources